Monitoring of Protein Biomarkers of Inflammation in Human Traumatic Brain Injury Using Microdialysis and Proximity Extension Assay Technology in Neurointensive Care.

With CCL11, we noticed lower levels (median NPX ∼2.5), with large individual variations and an increasing trend at the end of the observation period.

also in 63,971 other papers

Regarding other MCPs—i.e., MCP2 (CCL8)—we observed very high levels of the protein that were fairly consistent between patients with a slightly increasing trend during the first 100 h, followed by a decline in some patients, whereas others remained high.

also in 801 other papers